NCT07170592 2026-04-07A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor PatientsBionoxx Inc.Phase 1 Not yet recruiting24 enrolled
NCT06930352 2026-03-13Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard TherapyOhio State University Comprehensive Cancer CenterPhase 2 Not yet recruiting70 enrolled